![Samaritan Pharmaceuticals Company Logo](/news-release/logo/216057/0/216057.jpg?lastModified=12%2F09%2F2016%2022%3A56%3A06&size=2)
Samaritan Pharma: Early Stage Alzheimer's Disease Diagnostic Patent Issued in Australia
May 29, 2007 11:07 ET
|
Samaritan Pharmaceuticals, Inc.
LAS VEGAS, May 29, 2007 (PRIME NEWSWIRE) -- Samaritan Pharmaceuticals Inc. (AMEX:LIV), a developer of innovative drugs, announced today it has received a notice that the Australian patent application...
![Samaritan Pharmaceuticals Company Logo](/news-release/logo/216057/0/216057.jpg?lastModified=12%2F09%2F2016%2022%3A56%3A06&size=2)
Shire Human Genetic Therapies AB Signs Exclusive Marketing and Distribution Deal With Samaritan to Launch REPLAGAL for Fabry Disease in Greece and Cyprus
May 22, 2007 09:37 ET
|
Samaritan Pharmaceuticals, Inc.
LAS VEGAS, May 22, 2007 (PRIME NEWSWIRE) -- Samaritan Pharmaceuticals Inc. (AMEX:LIV) a developer of innovative drugs, is pleased to announce it has signed a second exclusive marketing and...
![Samaritan Pharmaceuticals Company Logo](/news-release/logo/216057/0/216057.jpg?lastModified=12%2F09%2F2016%2022%3A56%3A06&size=2)
Samaritan Breast Cancer Diagnostic Issued U.S. Patent
May 15, 2007 09:51 ET
|
Samaritan Pharmaceuticals, Inc.
Unique Advantages:
Faster Prognosis With Breast Cancer Diagnosis Taking 1-7 Days Compared
to the Traditional 3-Weeks
Determines Breast Cancer Tumor Aggressiveness and Likelihood of Cancer
...
![Samaritan Pharmaceuticals Company Logo](/news-release/logo/216057/0/216057.jpg?lastModified=12%2F09%2F2016%2022%3A56%3A06&size=2)
Samaritan Announces Positive Data in Nonclinical (IND) In-Vitro Studies for Promising Alzheimer's Drug
May 03, 2007 09:53 ET
|
Samaritan Pharmaceuticals, Inc.
LAS VEGAS, May 3, 2007 (PRIME NEWSWIRE) -- Samaritan Pharmaceuticals Inc. (AMEX:LIV), a developer of innovative drugs, is pleased to announce positive results were attained with its late-stage...
![Samaritan Pharmaceuticals Company Logo](/news-release/logo/216057/0/216057.jpg?lastModified=12%2F09%2F2016%2022%3A56%3A06&size=2)
Samaritan to Highlight Its Novel Alzheimer's Drug Caprospinol (SP-233) At BIO International Convention 2007
May 01, 2007 09:35 ET
|
Samaritan Pharmaceuticals, Inc.
LAS VEGAS, May 1, 2007 (PRIME NEWSWIRE) -- Samaritan Pharmaceuticals Inc. (AMEX:LIV), a developer of innovative drugs, announced today, it will present its late-stage preclinical drug candidates at...
![Samaritan Pharmaceuticals Company Logo](/news-release/logo/216057/0/216057.jpg?lastModified=12%2F09%2F2016%2022%3A56%3A06&size=2)
Samaritan Announces the Granting of European Patent for New Type of Cardiovascular Plaque Clearing Drug SP-1000
April 10, 2007 09:28 ET
|
Samaritan Pharmaceuticals, Inc.
LAS VEGAS, April 10, 2007 (PRIME NEWSWIRE) -- Samaritan Pharmaceuticals Inc. (AMEX:LIV), a developer of innovative drugs, announced today it has received a notice that a European Patent has been...
![Samaritan Pharmaceuticals Company Logo](/news-release/logo/216057/0/216057.jpg?lastModified=12%2F09%2F2016%2022%3A56%3A06&size=2)
AMEX Panel Grants Samaritan Continued AMEX Listing Pursuant to May 31st Extension to Allow for 10Q Filing Demonstrating It Has Regained Compliance
April 05, 2007 06:41 ET
|
Samaritan Pharmaceuticals, Inc.
LAS VEGAS, April 5, 2007 (PRIME NEWSWIRE) -- Samaritan Pharmaceuticals, Inc. (AMEX:LIV) announced today that on April 3, 2007, the American Stock Exchange ("AMEX") notified Samaritan Pharmaceuticals,...
![Samaritan Pharmaceuticals Company Logo](/news-release/logo/216057/0/216057.jpg?lastModified=12%2F09%2F2016%2022%3A56%3A06&size=2)
Samaritan Pharma Partners PII HIV Drug to Pharmaplaz; Upfront Payment $10 Million
March 28, 2007 11:53 ET
|
Samaritan Pharmaceuticals, Inc.
LAS VEGAS, March 28, 2007 (PRIME NEWSWIRE) -- Samaritan Pharmaceuticals Inc. (AMEX:LIV), a developer of innovative drugs, and Pharmaplaz, Ltd., a private Irish healthcare company, announced today...
![Samaritan Pharmaceuticals Company Logo](/news-release/logo/216057/0/216057.jpg?lastModified=12%2F09%2F2016%2022%3A56%3A06&size=2)
Samaritan Pharma's SP-233 Featured in Zillion Business Review Article
March 26, 2007 09:55 ET
|
Samaritan Pharmaceuticals, Inc.
LAS VEGAS, March 26, 2007 (PRIME NEWSWIRE) -- Samaritan Pharmaceuticals Inc. (AMEX:LIV) a developer of innovative drugs, announced today it was featured in the eighteenth edition 2007 of Zillion...
![Samaritan Pharmaceuticals Company Logo](/news-release/logo/216057/0/216057.jpg?lastModified=12%2F09%2F2016%2022%3A56%3A06&size=2)
Samaritan's In-Licensed AMPHOCIL Awarded 94 Percent Price Increase With Pricing Approval in Greece
March 08, 2007 09:46 ET
|
Samaritan Pharmaceuticals, Inc.
Sales Launch in Greece Expected Next Month
AMPHOCIL is the First of Nine Revenue Producing Products In-Licensed
to Samaritan
LAS VEGAS, March 8, 2007 (PRIME NEWSWIRE) -- Samaritan...